Vaxxinity

Democratizing health by creating vaccines for chronic diseases. 💛 #DemocratizeHealth

[TIME @TIME]

The new research is early, but it's a hopeful advance for patients with the neurological condition
https://t.co/yfOvmddauI

[BioSpace @biospace]

Vaxxinity published data from an early-stage clinical trial showing that its investigative immunotherapy, UB-312, could improve movement in Parkinson’s disease and protect against pathological alpha-synuclein.
#parkinsons #biospace
https://t.co/mbE1BCb2AA

[Vaxxinity @vaxxinity]

In case you missed it...
https://t.co/k5JdmrCm4O

[Vaxxinity @vaxxinity]

We're going after the root cause of Parkinson's.
https://t.co/XZtP2zZZgA

[World Vaccine Congress @vaccinenation]

News from @vaxxinity and @UF on a #collaboration to advance #vaccine development for #neurodegenerative diseases like #parkinsons and #alzheimers.
#vaccinenation #vaccines #disease #florida
https://t.co/pKhpDGUkpw

[Parkinson's News Today @parkinsonstory]

Under the agreement, @uf scientists will conduct preclinical studies exploring effects of vaccines for neurodegenerative diseases. See more: https://t.co/HmLjnRNL8V

#parkinsons #parkinsonsdisease #parkinsonsresearch #parkinsonstreatment

[Vaxxinity @vaxxinity]

Check out our executive chairman @NotLouReese on Cheddar News Friday: Vaxxinity Wants to Bring Accessible Vaccines for Chronic Illness to Market.

https://t.co/fUffrh9R3N

[Orlando Business Journal @OBJUpdate]

Vaxxinity Inc. will work with the University of Central Florida in Orlando to develop special new vaccines for astronauts that aim to prevent a common problem created during space exploration. Click for the details. https://t.co/hj80lIVl3O

[Longevity Technology @LongevityTech]

Could space travel research deliver a frailty vaccine?
@vaxxinity and UCF collaborate on muscle and bone wasting immunotherapies to benefit both space exploration and human longevity.
@NotLouReese #longevity #space #research #vaccine
https://t.co/LfxhdQL8SR

[Reuters @Reuters]

Researchers return to Alzheimer's vaccines, buoyed by recent drug success https://t.co/pHS5sVIXTP

[Vaxxinity @vaxxinity]

Our CEO, Mei Mei, has been recognized on the @PharmaVoice 100 list as an inspiring leader in the life-sciences space!

https://t.co/fmzI8bRA88

[Vaxxinity @vaxxinity]

Join us online next Monday, 9/11 at 10am ET! You won’t want to miss the latest corporate update from our CEO. Watch live here: https://t.co/rF45xMtsCY

[Vaxxinity @vaxxinity]

Looking forward to presenting in September. Our H.C. Wainwright presentation will be broadcast live to the public. Tune in!

https://t.co/OQhrgxF8oE

[Maersk @Maersk]

Meet our Hidden Hero Rob Townley who work with some of our most complex and high risk projects at @Maersk👊Learn more about how Rob helps bring our #purpose to life⭐
👉Watch the full video: https://t.co/RNsWouAHwx
#Maersk #HiddenHero #alltheway #Career

[NeurologyLive® @neurology_live]

Jean-Cosme Dodart (@vaxxinity) discussed recently published trial findings on a novel vaccine that targets Alzheimer's disease and triggers the production of antibodies against toxic amyloid-ß peptides.

Watch here 👇 https://t.co/1vlSxYqoRN

[NeurologyLive® @neurology_live]

#ICYMI: Phase 1 trial results investigating UB-312 (@vaxxinity) revealed target engagement of aggregated alpha-synuclein in cerebrospinal fluid of patients with Parkinson disease.

Read more: https://t.co/hE8kyGuPDA

[Healio Neurology @healioneurology]

Treatment with an investigational anti-#amyloid therapeutic for adults with mild #AD was safe, efficacious and demonstrated a significant immune response up to 78 weeks, per a @Vaxxinity study published in @eBioMedicine. https://t.co/CqPkdxsHV6

[Vaxxinity @vaxxinity]

Thought leader @DrJeffCummings sums up our latest publication in The Lancet’s @eBioMedicine about UB-311, the active vaccine candidate targeting beta-amyloid.

https://t.co/7DBkMUYJJm

[Health Radio Online @HealthProRadio]

Vaxxinity - Expansively Disrupting Medicine
Read more: https://t.co/u7YuKqRJEy
#ChronicDiseaseVaccines

[ADI @AlzDisInt]

Did you miss last week's fireside chat on vaccines for #dementia?

If so, you can find the inspiring & informative 30-minute conversation with ADI's @WeidnerWendy, @AC_Immune_SA's Andrea Pfeifer & Mei Mei Hu of @vaxxinity, on our YouTube channel. https://t.co/Smn6LvoTS9